Predicting Need for Escalation of Care or Death From Repeated Daily Clinical Observations and Laboratory Results in Patients With Severe Acute Respiratory Syndrome Coronavirus 2. Issue 11 (22nd July 2022)

• Record Type: Journal Article
• Authors: Crooks, Colin J; West, Joe; Fogarty, Andrew; Morling, Joanne R; Grainge, Matthew J; Gonem, Sherif; Simmonds, Mark; Race, Andrea; Juurlink, Irene; Briggs, Steve; Cruickshank, Simon; Hammond-Pears, Susan; Card, Timothy R
• Is Part Of: American journal of epidemiology. Volume 191:Issue 11(2022)
• Page Start: 1944
• Page End: 1953
• Publication Date: 2022-07-22
• Subjects: coronavirus disease 2019 -- COVID-19 -- critical care -- mortality -- SARS-CoV-2 -- severe acute respiratory syndrome coronavirus 2 -- survival analysis; Epidemiology -- Periodicals; Public health -- Periodicals; 614.4
• DOI: 10.1093/aje/kwac126
• Languages: English
• ISSNs: 0002-9262

Abstract

Abstract: We compared the performance of prognostic tools for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using parameters fitted either at the time of hospital admission or across all time points of an admission. This cohort study used clinical data to model the dynamic change in prognosis of SARS-CoV-2 at a single hospital center in the United Kingdom, including all patients admitted from February 1, 2020, to December 31, 2020, and then followed up for 60 days for intensive care unit (ICU) admission, death, or discharge from the hospital. We incorporated clinical observations and blood tests into 2 time-varying Cox proportional hazards models predicting daily 24- to 48-hour risk of admission to the ICU for those eligible for escalation of care or death for those ineligible for escalation. In developing the model, 491 patients were eligible for ICU escalation and 769 were ineligible for escalation. Our model had good discrimination of daily risk of ICU admission in the validation cohort ( n = 1, 141; C statistic: C = 0.91, 95% confidence interval: 0.89, 0.94) and our score performed better than other scores (National Early Warning Score 2, International Severe Acute Respiratory and Emerging Infection Comprehensive Clinical Characterisation Collaboration score) calculated using only parameters measured on admission, but it overestimated the risk of escalation (calibration slope = 0.7). A bespoke daily SARS-CoV-2 escalation risk prediction score can predict the need for clinical escalation better than a generic early warning score or a single estimation of risk calculated at admission.